---
title: Treatment of Foot and Leg Ulcers Using a Laser
nct_id: NCT03955289
overall_status: COMPLETED
sponsor: University of Texas Southwestern Medical Center
study_type: OBSERVATIONAL
primary_condition: Diabetic Foot Ulcer
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT03955289.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT03955289"
ct_last_update_post_date: 2023-07-24
last_seen_at: "2026-05-12T06:02:58.114Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Treatment of Foot and Leg Ulcers Using a Laser

**NCT ID:** [NCT03955289](https://clinicaltrials.gov/study/NCT03955289)

## Key Facts

- **Status:** COMPLETED
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 34
- **Lead Sponsor:** University of Texas Southwestern Medical Center
- **Conditions:** Diabetic Foot Ulcer
- **Start Date:** 2019-01-15
- **Completion Date:** 2019-02-01
- **CT.gov Last Update:** 2023-07-24

## Brief Summary

The investigators plan to do a retrospective chart review on patients who underwent laser treatment for their foot ulcer at the UT Southwestern wound clinic.

## Detailed Description

The investigators plan to do a retrospective chart review on patients who underwent laser treatment for their foot ulcer at the UT Southwestern wound clinic starting on May 17, 2018 to November 13, 2018. The investigators chose this date because that is the first time laser treatments were performed in the clinic. The investigators will collect the following data points:

* Ulcer etiology
* Ulcer location
* Prior ulcer treatment type and duration, and wound measurements/characteristics
* Wound size 4-6 weeks prior to laser treatment; at treatment time; and then each follow up measurement healed or x weeks
* eGFR
* Albumin
* Last A1c-Presence/absence of DM
* Amputation history
* Vascular status via ABI's
* Identify comorbidities
* Identify associated encounters in the patients such as complications (i.e. infection), related readmissions The investigators will identify this information from patient charts (EPIC EMR).

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* patients who underwent laser treatment for their foot ulcer at the UT Southwestern wound clinic starting on May 17, 2018 to November 13, 2018

Exclusion Criteria:

* not meeting inclusion criteria
```

## Primary Outcomes

- **Improved healing rate to time to healing** _(time frame: 4 weeks)_ — Wounds assessed in this study will show significant improvement in wound characteristics after Erbium-YAG laser debridement(s). Improved healing rate to time to healing.

## Secondary Outcomes

- **Decreased complications in diabetic foot ulcers, i.e. infection, hospital admission, amputation** _(time frame: 4 weeks)_

## Locations (1)

- UT Southwestern Medical Center at Dallas, Dallas, Texas, United States

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.ut southwestern medical center at dallas|dallas|texas|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT03955289.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT03955289*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*